FDA Grants Fast Track Designation for Gene Therapy Candidate LX2006 in Friedreich Ataxia Cardiomyopathy Neurology Live, 27 Apr 2024 In recent news, Lexeo Therapeutics' gene therapy candidate LX2006 received FDA fast track designation for patients with…